Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin‐mediated amyloidosis with polyneuropathy

Garcia‐Pavia, P., Grogan, M., Kale, P., Berk, J. L., Maurer, M. S., Conceição, I., Di Carli, M., Solomon, S. D., Chen, C., Yureneva, E., Vest, J., & Gillmore, J. D. (2024). Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin‐mediated amyloidosis with polyneuropathy. European Journal of Heart Failure, 26(2), 397–410. Portico. https://doi.org/10.1002/ejhf.3138
Authors:
Pablo García‐Pavía
Martha Grogan
Parag Kale
John L. Berk
Mathew S. Maurer
Isabel Conceição
Marcelo F. Di Carli
Scott D. Solomon
Chongshu Chen
Elena Yureneva
John Vest
Julian D. Gillmore
Affiliated Authors:
Mathew S. Maurer
Columbia Affiliation:
Subjects:
Heart Failure (MeSH)
Amyloid Neuropathies, Familial (MeSH)
Polyneuropathies (MeSH)
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression (OpenAlex Topic)
Molecular Mechanisms of Ras Signaling Pathways (OpenAlex Topic)
Author Keywords:
vutrisiran
hereditary transthyretin-mediated amyloidosis
cardiomyopathy
nt-probnp
echocardiography
tc-99m scintigraphy
<sup>99m</sup>tc scintigraphy
99mtc scintigraphy
hereditary transthyretin‐mediated amyloidosis
nt‐probnp
elink
Publication Type:
Article
Unique ID:
10.1002/ejhf.3138
PMID:
38321786
DOI:
10.1002/ejhf.3138
Journal:
European Journal of Heart Failure
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: